A Phase 1, Double-Blind, Placebo-Controlled, Sponsor Open, Randomized, Multiple Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-04447943 In Mild To Moderate Alzheimer's Disease Subjects On Stable Donepezil Therapy.
Phase of Trial: Phase I
Latest Information Update: 20 Jul 2011
At a glance
- Drugs PF 4447943 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 20 Jul 2011 Results presented at the 2011 International Conference on Alzheimer's Disease.
- 06 Aug 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 06 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.